Top Markets
Coin of the day
CinCor Pharma, Inc. CinCor Pharma, Inc.

CinCor Pharma, Inc.

CINC
Clasificación en acciones #11594
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Precio por acción
$29.06
Última sincronización: 2023-02-23
Capitalización bursátil
$682.73M
Cambio (1 día)
-0.48%
Cambio (1 año)
0.00%
País
US
Comercio CinCor Pharma, Inc. (CINC)

Categoría

Historial del precio de la acción de CinCor Pharma, Inc. (CINC)
Precio más alto de cierre: $29.26 el 2023-02-01

Precio más bajo de cierre: $16.50 el 2022-01-01
Historial del precio de la acción de CinCor Pharma, Inc. desde 2022 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2023 146.11%
2022 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$542.09 38.63%
US
$1.03K 44.13%
NL
$121.53 -12.70%
AU
$138.18 473.58%
US
$759.27 7.20%
CH